vimarsana.com

German Customs Authorities News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook

Q1 2022 total revenue was $8.7 million, including product sales of $7.9 million.  Core non-COVID-19 product sales were an estimated $7.6 million, .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.